Jasper Therapeutics JSPR
NASDAQ JSPR
$0.51 +0.01 (+1.10%)
As of: Oct 21, 2026 · 11:31 AM EDT

Jasper Therapeutics (JSPR) Operating Margin (2021 - 2023)

Updated

Analysis

Jasper Therapeutics (JSPR) Operating Margin (2021 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,130.38 Bn 1,098.96 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 613.84 Bn 532.37 Bn 17.26 Bn 28.21%
3 AbbVie 502.13 Bn 475.24 Bn 12.70 Bn 37.86%
4 Merck 367.76 Bn 322.14 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.08 Bn 262.07 Bn 11.24 Bn 32.97%
6 Astrazeneca 262.03 Bn 235.71 Bn 12.86 Bn 20.57%
7 Amgen 235.81 Bn 191.21 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.97 Bn 165.17 Bn 6.22 Bn -133.21%
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn 28.37%
10 Jasper Therapeutics 14.50 Mn -111.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -37,964.71%
Sep 30, 2022 -141,200.00%
Jun 30, 2021 -210,450.00%
Mar 31, 2021 -625,400.00%
API Access

Jasper Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=JSPR&period=max&api_key=YOUR_API_KEY